ライフサイエンスコーパス: bolus

1 be activated within 30 min of the alteplase bolus.

2 f 500 mL of crystalloid solution or no fluid bolus.

3 ntify subgroups that differed in response to bolus.

4 eceived no steroids after the intraoperative bolus.

5 t; 138 to sitagliptin-basal and 139 to basal-bolus.

6 fines of the bleb created by the intradermal bolus.

7 d changes in vasopressor support after fluid bolus.

8 genous ketone ester (d-beta-hydroxybutyrate) bolus.

9 (interquartile range 3.7-4.6) received fluid bolus.

10 The next cohort received 0.2-1 x 10(13) vg boluses.

11 .6% +/- 3.8% less than that of the first two boluses.

12 hin liquid, thick liquid, puree, and cracker boluses.

13 nd at rest following an intravenous contrast bolus (0.05 mmol/kg, gadobutrol).

14 L-1, P = 0.039] and infant cobalamin intake [Bolus: 0.023 (0.020, 0.027) mug; Control: 0.015 (0.013,

15 the Bolus dose increased cobalamin in milk [Bolus: 0.054 (0.047, 0.061) mug . min-1 . mL-1; Control:

16 trol: 34.5 (30.0, 39.6) mug], thiamin [milk: Bolus: 10.9 (10.1, 11.7) mug . min-1 . mL-1; Control: 7.

17 ildren in the cardiac ICU who received fluid bolus (10mL/kg of Ringers-Lactate over 30 min) for manag

18 Aspiration Scale score >= 6) on at least one bolus, 13.6% (n = 29) exhibited silent aspiration, and 2

19 milk and infant intakes of riboflavin [milk: Bolus: 154.4 (138.2, 172.5) mug . min-1 . mL-1; Control:

20 s in a random order: bolus 30-g dose of LNS (Bolus); 3 x 10-g doses of LNS (Divided); and no LNS (Con

21 d to receive 3 treatments in a random order: bolus 30-g dose of LNS (Bolus); 3 x 10-g doses of LNS (D

22 ived intraocular vancomycin via intracameral bolus (33/36), via intravitreal injection (1/36), or thr

23 0.8 (55.8, 66.3) mug . min-1 . mL-1; infant: Bolus: 39.4 (33.5, 46.4) mug; Control: 25.0 (21.4, 29.2)

24 ed intravenously over 2 h), and fluorouracil bolus 400 mg/m(2) administered intravenously over 5 min,

25 : 7.7 (7.2, 8.3) mug . min-1 . mL-1; infant: Bolus: 5.1 (4.4, 6.0) mug; Control: 3.4 (2.9, 4.0) mug],

26 olus group (48 [29%]) compared with no fluid bolus (59 [35%]).

27 4.5 (75.8, 94.3) mug . min-1 . mL-1; infant: Bolus: 64.5 (56.1, 74.3) mug; Control: 34.5 (30.0, 39.6)

28 ing a (67)Ga-, (111)In-, or (177)Lu-NeoBOMB1 bolus (74, 74, or 370 kBq, respectively, 100 muL, 10 pmo

29 ompared with those randomized to intravenous bolus (9.2% vs. 17.6%; hazard ratio [HR]: 0.49; 95% conf

30 l: 3.4 (2.9, 4.0) mug], and pyridoxal [milk: Bolus: 90.5 (82.8, 98.9) mug . min-1 . mL-1; Control: 60

31 o 11.1 ng per milliliter after the andexanet bolus (92% reduction; 95% confidence interval [CI], 91 t

32 yngeal pathology was evaluated, and for each bolus, a Penetration Aspiration Scale score was assigned

33 tongue base retraction (TBR) drives the food bolus across the oropharynx towards the esophagus and fl

34 NO decay in SMCs was measured following bolus addition of NO to air-equilibrated cells.

35 Pharmacokinetic profiling of a bolus administration into the glenohumeral joint space r

36 All subjects underwent one 2-h scan after a bolus administration of (11)C-AS2471907.

37 Neos vibrating membrane nebulizer system, 2) bolus administration using the Intubation Surfactant Ext

38 is (n = 107) that included intravenous fluid bolus administration with monitoring of jugular venous p

39 After the bolus administration, the median anti-factor Xa activity

40 hed tablets at the time of cangrelor/placebo bolus administration.

41 ed potency and low plasma exposure following bolus administration.

42 h additional protection achieved by a second bolus after the induction procedure.

43 Fluid boluses aiming to improve the cardiac output and oxygen

44 =40), tirofiban (n=40) (both administered as bolus and 2-hour infusion followed by 60 mg of prasugrel

45 In-vivo MPI mouse images of a 512 ng bolus and a 21.5 ms acquisition time allow for capturing

46 312), out-of-hospital tranexamic acid (2 g) bolus and in-hospital placebo 8-hour infusion (bolus onl

47 group; n = 345), and out-of-hospital placebo bolus and in-hospital placebo 8-hour infusion (placebo g

48 f TBI: out-of-hospital tranexamic acid (1 g) bolus and in-hospital tranexamic acid (1 g) 8-hour infus

49 (Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over Prasugrel: A Multicenter Randomi

50 IC), or FOLFOX (oxaliplatin, leucovorin, and bolus and infusional fluorouracil).

51 ing for dramatic contrast changes during the bolus and long execution times.

52 haemoglobin and plasma biochemistry between bolus and non-bolus patients, assessed the effects of th

53 fects of administration of intravenous fluid boluses and vasopressors in patients with sepsis across

54 mug/kg/d) or terlipressin (single 2-mg i.v. bolus), and the regional hemodynamic effects were quanti

55 within 4 hours, despite two additional fluid boluses, and resulted in significant volume retention.

56 jection, MicronJet administration of a 50muL bolus appears to create multiple superficial microdisrup

57 constant-infusion scan matched that from the bolus application (test-retest variability, 1.1% +/- 24.

58 Sedation by IV propofol bolus application delayed after controlled cortical impa

59 ase of SDF-1 from PPCN (PPCN+SDF-1) versus a bolus application of SDF-1 in phosphate buffered saline

60 parate bursts, mimicking the delivery of two boluses approximately one month apart.

61 eral (iron, zinc, magnesium) transfer to the bolus aqueous phase during the digestion of meals with/w

62 ects of epinephrine diminish with successive boluses as the impact of the third bolus on brain oxygen

63 exposure applied chronically, or as a single bolus at postnatal day 1, markedly worsened AAA outcomes

64 in seconds and results in a concentrated DNA bolus at the capillary orifice.

65 ed to intracoronary or intravenous abciximab bolus at the time of primary PCI.

66 , squeezing the midline tongue base and food bolus back into the oropharynx.

67 and individualized approach to repeat fluid bolus based solely on lack of mean arterial pressure res

68 300 mg/dL) followed by intravenous arginine bolus before and after 72-h glucose infusion.

69 5 mg/kg (maximum, 25 mg; n = 150) given as a bolus before endovascular thrombectomy.

70 tion of febrile children, albumin and saline boluses can cause respiratory and neurological dysfuncti

71 uggests that an intravenous or intestinal Pi bolus causes rapid phosphaturia through mechanisms requi

72 lymphopenia and/or history of corticosteroid boluses could be useful to avoid life-threatening compli

73 ntified with PET/unenhanced CT and PET/split-bolus CT.

74 ed chronically by either 2 carbohydrate-rich boluses daily or a continuous isocaloric intragastric in

75 Intraperitoneal bolus dantrolene before HAL prolongs time to respiratory

76 ed US with VEGFR2-targeted microbubbles, (b) bolus DCE US with nontargeted microbubbles, and (c) dest

77 ed to evaluate the effects of prolonged post-bolus delay and varied labeling size.

78 hin bone marrow, the use of a prolonged post-bolus delay caused excessive perfusion signal decay, res

79 Administration of an intravenous fluid bolus did not decrease the overall incidence of cardiova

80 Copper-containing boluses did not consistently affect abundance of arthrop

81 d into 3 groups: control (group 1), one i.v. bolus DNase I before CPB start (group 2) and a second DN

82 estimate FA FSR in cord blood with this oral bolus dose approach.

83 Only the Bolus dose increased cobalamin in milk [Bolus: 0.054 (0.

84 ridoxal and infant intakes, whereas only the Bolus dose increased cobalamin.

85 blood pressure (-3.5 mm Hg), and mean daily bolus dose of insulin (-2.8 units per day) (P</=0.002 fo

86 ght, systolic blood pressure, and mean daily bolus dose of insulin.

87 sion was not changed within 72 h following a bolus dose of TCDD.

88 eate a mouse model of TIH, we administered 4 bolus doses of glucose at 2-hour intervals intraperitone

89 rapidly normalize blood glucose levels with bolus doses of insulin and rapid insulin titration.

90 Bolus doses of the first treatment step were lower than

91 -administer intravenous medications in small bolus doses.

92 bility and hypoglycemia through avoidance of bolus dosing, a liberalized blood glucose target, and gr

93 ating to an in vivo rat model, 2 weeks after bolus doxorubicin injection, there was a dose-dependent

94 Studies on epinephrine administration as bolus (e.g., during cardiopulmonary resuscitation), were

95 High-risk patients had bolus epinephrine preordered and prepared for immediate

96 Bolus epinephrine was administered during 110 hypotensio

97 eptic Shock and hydrocortisone at a 50 mg IV bolus every 6 hr and fludrocortisone as a 50 mug tablet

98 cal dysfunction induced by saline or albumin bolus explained the excess mortality due to bolus in Cox

99 ntration although this fall was greater with bolus feeding (P < 0.0001).

100 Bolus feeding increased body temperature and reduced wei

101 ed to limit peak dead-time losses during the bolus first-pass transit.

102 entration were significantly decreased after bolus fluid administration.

103 eceived postoperative chemoradiotherapy with bolus fluorouracil (FU) and leucovorin (LV) compared wit

104 in 350 mg infusion over 2 h, and 400 mg/m(2) bolus fluorouracil followed by a 2400 mg/m(2) continuous

105 over 2 h, 200 mg leucovorin, and 400 mg/m(2) bolus fluorouracil followed by a 2400 mg/m(2) continuous

106 t with either cangrelor or matching placebo (bolus followed by 2-hour infusion).

107 at 140 mg/m(2), and fluorouracil 400 mg/m(2) bolus followed by 2400 mg/m(2) over 46 h).

108 B2452 administered as an initial intravenous bolus followed by a prolonged infusion (8, 12, or 16 hou

109 ioligand [(11)C]AZ10419369 administered as a bolus followed by constant infusion to measure changes i

110 was performed using volume expansion (saline bolus) followed by phenylephrine.

111 eive caplacizumab (10-mg intravenous loading bolus, followed by 10 mg daily subcutaneously) or placeb

112 etate, potently suppresses the conversion of bolus fructose into hepatic acetyl-CoA and fatty acids.

113 al concentration of l-fucose following an IP bolus given before the ischemia induction procedure - a

114 was not significantly different in the fluid bolus group (48 [29%]) compared with no fluid bolus (59

115 ith 31 (18%) of 169 patients in the no fluid bolus group (absolute difference 1.3% [95% CI -7.1% to 9

116 tin-basal group and in 17 (12%) in the basal-bolus group (p=0.45).

117 tin-basal group versus 26 (19%) in the basal-bolus group (p=0.54).

118 2.7]) was not inferior to that in the basal-bolus group 9.4 mmol/L [2.7]) with a mean blood glucose

119 red in 33 (20%) of 168 patients in the fluid bolus group compared with 31 (18%) of 169 patients in th

120 olic blood pressure <65 mm Hg 11 [7%] in the bolus group vs ten [6%] in the no-bolus group, new or in

121 lin lispro or aspart before meals (the basal-bolus group) during the hospital stay.

122 ) developed acute pancreatitis (in the basal-bolus group).

123 7%] in the bolus group vs ten [6%] in the no-bolus group, new or increased vasopressor 32 [19%] vs 31

124 liptin-basal group and six (4%) in the basal-bolus group.

125 ed H(2)O(2) In contrast, when delivered as a bolus, H(2)O(2) induced the DNA damage response, deplete

126 The following two boluses had no beneficial effects on creatinine clearanc

127 bone marrow (BM) plasma cells compared with bolus immunization.

128 s promotes humoral immunity, but traditional bolus immunizations lead to rapid antigen clearance.

129 nt non-neutralizing epitopes by conventional bolus-immunized animals, whereas slow delivery-immunized

130 The mean arterial pressure response to fluid bolus in cardiac ICU patients was unpredictable with a p

131 bolus explained the excess mortality due to bolus in Cox survival models.

132 he microbial communities associated with the bolus in the stomach, intestine, cecum, and colon of fiv

133 critically ill adults compared with no fluid bolus in this trial.

134 There were similar effects of fluid bolus in three patient subgroups, identified on the basi

135 nfusion is better tolerated than intravenous boluses in the treatment of type 1 HRS.

136 uous intravenous infusion versus intravenous boluses in the treatment of type 1 HRS.

137 In FEAST, fluid bolus increased respiratory and neurological scores and

138 We hypothesised that fluid bolus-induced deaths in FEAST would be associated with d

139 Bolus-induced deglutitive and post-prandial reflux occur

140 Nuclear scintigraphy delineated bolus-induced deglutitive reflux events (29.6% vs. 62.5%

141 d-type (WT) littermates underwent an insulin bolus-induced hypoglycemia test and a low-dose hyperinsu

142 intravenous idarucizumab, administered as 2 bolus infusions of 2.5 g no more than 15 minutes apart.

143 affective and sensory experiences following bolus infusions of either isoproterenol, a rapidly actin

144 ause disease regression at levels similar to bolus infusions of ex vivo engineered lymphocytes.

145 Bolus infusions of saline and isoproterenol (1 or 2 mug)

146 es postorder; and 4) 30 mL/kg IV crystalloid bolus initiated less than or equal to 30 minutes from "t

147 Atropine bolus injection (0.04 mg/kg) did not increase heart rate

148 to receive doxorubicin alone (75 mg/m(2) via bolus injection administered over 5-20 min or continuous

149 otency and duration of action on intravenous bolus injection in diabetic rats are indistinguishable f

150 T scans at 0, 15, 90, 120, and 180 min after bolus injection of (123)I-mIBG on a hybrid cadmium zinc

151 dynamic PET imaging for up to 120 min after bolus injection of (18)F-T807 with arterial blood sampli

152 c mild cognitive impairment subjects after a bolus injection of 152-169 MBq of (18)F-MK-6240 to evalu

153 formed concurrently with a rapid intravenous bolus injection of 232 +/- 82 MBq of (18)F-FGln, followe

154 nderwent a dynamic PET scanning session with bolus injection of [(11)C]DAA1106 (with smokers in the s

155 lycolytic flux in a murine tumor model after bolus injection of D-[6,6'-(2)H(2)]glucose before and 48

156 In cynomolgus macaques, a bolus injection of di-siRNA showed substantial distribut

157 s were acquired before and dynamically after bolus injection of gadoxetate disodium, normal saline, a

158 , 2) the apneic response to the right atrial bolus injection of phenylbiguanide (a 5-HT(3)R agonist)

159 nd (ii) with transient changes in BP using a bolus injection of SNP (ARISNP ) and PhE (ARIPhE ).

160 Bolus injection through peripherally inserted central ca

161 ry thermodilution measurements obtained with bolus injection through peripherally inserted central ca

162 us infusion for 2 weeks compared to a single bolus injection.

163 s over 240 min after intravenous radiotracer bolus injection.

164 Repeated bolus injections are associated with higher costs and po

165 Bolus injections of microbubbles at 4 muL/kg were tested

166 When compared to bolus injections, a bubble infusion offers a more contro

167 sponses observed after multiple subcutaneous bolus injections, and led to immune protection against a

168 us insulin), 2) hyperinsulinemic euglycemia (bolus insulin and glucose infusion), and 3) saline contr

169 t alternative to, the labour-intensive basal-bolus insulin regimen for the management of hyperglycaem

170 sitagliptin) plus basal insulin with a basal-bolus insulin regimen for the management of patients wit

171 tudy days: 1) hyperinsulinemic hypoglycemia (bolus insulin), 2) hyperinsulinemic euglycemia (bolus in

172 atments administered randomly, all as a 1 mm bolus, into the perfusate: saline vehicle (control); sod

173 emen donation who were eligible for standard bolus intra-uterine insemination (IUI).

174 3:1 ratio to receive HTT(Rx) or placebo as a bolus intrathecal administration every 4 weeks for four

175 tandard induction chemotherapy (daunorubicin bolus intravenous infusion on days 1-3 [90 mg/m(2) for p

176 Intravenous glyburide was given as a 0.13 mg bolus intravenous injection for the first 2 min, followe

177 Bolus intravenous injections of microbubbles are standar

178 d during pump speed adjustment and following bolus intravenous milrinone to assess changes in loading

179 The goal of this initial bolus is to quickly treat cerebral edema.

180 osed-loop insulin delivery without meal-time boluses is effective and safe in insulin-treated adults

181 ht be improved with SRI compared to standard bolus IUI, especially in women aged under 35 years.

182 ivo signaling was evaluated after an insulin bolus just prior to weaning (n = 4-5/group).

183 pital tranexamic acid (1 g) 8-hour infusion (bolus maintenance group; n = 312), out-of-hospital trane

184 ndle that included early intravenous nitrate boluses; management of precipitating factors, such as ac

185 Uncontrolled bolus methods provide limited understanding of target en

186 ifferences between the bolus (n=2097) and no bolus (n=1044) groups of FEAST.

187 orts and to identify differences between the bolus (n=2097) and no bolus (n=1044) groups of FEAST.

188 with EoE since 2004, had a total esophageal bolus obstruction while eating lunch at the local hospit

189 ope resolved metabolomics (SIRM) following a bolus of (13)C(6)-glucose.

190 ta were acquired during 50 min after a 1-min bolus of (18)F-FET.

191 nterval, with each challenge consisting of a bolus of 1 ng/kg followed by continuous administration o

192 athy exhibiting neurologic manifestations, a bolus of 100 mL of 3% saline, given over 10 minutes, sho

193 nts were randomly assigned to receive either bolus of albumin in a lactated Ringer's solution or lact

194 The patients received a bolus of andexanet, followed by a 2-hour infusion.

195 ed in 3 arms (A): A1 received an intravenous bolus of atorvastatin during MI; A2 received an intraven

196 ively), and that the consumption of a single bolus of dietary nitrate (12.8 mmol) significantly eleva

197 avity CNPE has a fast temporal response to a bolus of dopamine that is not different from that of a t

198 This one bolus of fat resulted in a measurable increase in insuli

199 The arterial bolus of gadoxetate disodium arrived later than gadotera

200 ynthesized DNA and observed that a sublethal bolus of glycine chloramine, but not H(2)O(2), significa

201 guidelines adopted the approach of giving a bolus of hypertonic saline.

202 mg/m(2) per day on days 1-7) and intravenous bolus of idarubicin (12 mg/m(2) per day on days 1-3).

203 us, basiliximab, mycophenolate mofetil and 1 bolus of intraoperative corticosteroids (0-1000 mg) as p

204 ibiotics and to the completion of an initial bolus of intravenous fluid.

205 but not a longer time to the completion of a bolus of intravenous fluids (odds ratio, 1.01 per hour;

206 tics, but not rapid completion of an initial bolus of intravenous fluids, were associated with lower

207 e retinal pigment epithelium (RPE) ingests a bolus of lipid and protein in the form of phagocytized p

208 d to a greater extent than a leucine-matched bolus of milk protein, in resistance-trained young men.

209 mycoprotein compared with a leucine-matched bolus of milk protein, in rested and exercised muscle of

210 thetic response to the ingestion of a single bolus of mycoprotein compared with a leucine-matched bol

211 The ingestion of a single bolus of mycoprotein stimulates resting and postexercise

212 on, we demonstrate that a single intravenous bolus of n-apo AI (CSL111, 80 mg/kg) delivered immediate

213 A single intravenous bolus of n-apo AI delivered immediately post-myocardial

214 tric emptying, as assessed following an oral bolus of phenol red or independently by [(99m)Tc]-diethy

215 Instead, we track a bolus of solutes or nanoparticles using particle trackin

216 of an outer envelope, an inner matrix, and a bolus of sperm.

217 statin during MI; A2 received an intravenous bolus of vehicle during MI; and A3 received oral atorvas

218 to examine the impact of a single high-dose bolus of vitamin D3 followed by maintenance treatment gi

219 -induced HF received incremental intravenous boluses of PDE9-I (30, 100, and 300 mg PF-04749982 at 1-

220 the initial dose of 2 mg/day or intravenous boluses of terlipressin (TERLI-BOL group) at the initial

221 in Vasoactive-Inotrope Score after the fluid bolus, of whom 60% received higher level of vasoactive s

222 uccessive boluses as the impact of the third bolus on brain oxygen metabolism was 24.6% +/- 3.8% less

223 was administered as a 15 mg/m(2) intravenous bolus on day 1 and 10 mg/m(2) intravenous bolus on days

224 us bolus on day 1 and 10 mg/m(2) intravenous bolus on days 3, 6, and 11 after HCT; tacrolimus was giv

225 ation was mimicked by an intravenous insulin bolus on placebo day.

226 lus and in-hospital placebo 8-hour infusion (bolus only group; n = 345), and out-of-hospital placebo

227 lus versus those receiving an intraoperative bolus only.

228 Maternal supplementation with the Bolus or Divided dose increased least-squares mean (95%

229 Maternal supplementation with LNS as a Bolus or Divided dose was similarly effective at increas

230 ib (1.3 mg/m(2)) was given as an intravenous bolus or subcutaneous injection on days 1, 4, 8, and 11

231 ion) or bortezomib (1.3 mg/m(2); intravenous bolus or subcutaneous injection) and dexamethasone (20 m

232 ned (1:1) to ketamine (0.5 mg/kg intravenous bolus) or saline adjunctive to the anaesthetic for the d

233 g insulin analogue without meal-time insulin boluses) or conventional subcutaneous insulin delivery a

234 s were randomly assigned to receive either a bolus oral dose of 100,000 IU cholecalciferol followed b

235 nd plasma biochemistry between bolus and non-bolus patients, assessed the effects of these factors al

236 ts, the radiotracer was administered using a bolus-plus-infusion protocol, the arterial input functio

237 the curve 6 hours following fructose/glucose bolus (R(2) = -0.554, P = 0.005).

238 Fluid bolus recipients had mean 0.33 g/dL (95% CI 0.20-0.46) r

239 ily (the sitagliptin-basal group) or a basal-bolus regimen with glargine once daily and rapid-acting

240 f the CT scan relative to the contrast media bolus remains a challenging task given the shorter scan

241 In mice, the saturated fat bolus resulted in the induction of several NAFLD-associa

242 Epinephrine administration by bolus resulted in transient improvements in cerebral oxy

243 l pressure initially decreased further under bolus resuscitation (-10 mm Hg; p < 0.001) and was lower

244 n (-10 mm Hg; p < 0.001) and was lower under bolus resuscitation than closed loop at 20 minutes (bolu

245 In comparison with formula-based bolus resuscitation, both semiautonomous and autonomous

246 on systems and compare them to formula-based bolus resuscitation.

247 loop and were significantly increased under bolus resuscitation.

248 0.001), plasma volume, extravascular volume (bolus resuscitation: 17 +/- 4 mL/kg, decision assist: 3

249 Colloid osmotic pressure (bolus resuscitation: 19.3 +/- 2 mm Hg, decision assist,

250 morrhage, the total amount of infused fluid (bolus resuscitation: 30 mL/kg, decision assist: 5.6 +/-

251 esuscitation than closed loop at 20 minutes (bolus resuscitation: 57 +/- 2 mm Hg, closed loop: 69 +/-

252 n scheme on separate visits 1) formula-based bolus resuscitation; 2) semiautonomous (decision assist)

253 If signs persist, the bolus should be repeated in order to achieve clinical re

254 ug was administered intraoperatively as 5-mL bolus (somatostatin: 500 mug), followed by a 2.5 mL/h in

255 ere confirmed, even after standardization of bolus speed with automated injection.

256 cin, 3% remdesivir, 21% tocilizumab, and 24% bolus steroids.

257 -monomethyl-l-arginine (l-NMMA, 5 mg kg(-1) bolus & subsequent 50 mug kg(-1) min(-1) maintenance dos

258 m brainstem regions) remaining higher in the bolus surfactant than in the aerosolized surfactant grou

259 story as well as the absence of bones in the bolus, the patient was submitted to a new conservative t

260 After 24, 25, and 26 hours of sepsis, fluid bolus therapy (500 mL of Hartmann's solution over 15 min

261 These initial effects of fluid bolus therapy dissipated within 4 hours, despite two add

262 The first fluid bolus therapy increased blood pressure (+6% +/- 1%), cen

263 perimental septic acute kidney injury, fluid bolus therapy transiently improved renal function and me

264 enation dissipated following the third fluid bolus therapy.

265 ) has acceptable agreement with intermittent bolus thermodilution over a wide range of cardiac output

266 surement and a pulmonary artery catheter for bolus thermodilution.

267 c motility that traces the passage of a food bolus through the stomach over a 30 minutes time period.

268 the vital sign scores on the contribution of bolus to mortality using Cox proportional hazard models,

269 luate administration of an intravenous fluid bolus to prevent cardiovascular collapse during intubati

270 olol), the median time from 15 mg metoprolol bolus to reperfusion was 53 min.

271 hout the tumor rather than given as a single bolus to the tumor center.

272 elected prodrugs of PKC modulators avoid the bolus toxicities of the parent drug and exhibit greater

273 giography of the thoracoabdominal aorta with bolus tracking was performed in two different study coho

274 e 120-140 ml was injected automatically with bolus tracking).

275 usion Compared with a fixed delay time after bolus tracking, a patient-specific individualized trigge

276 ume 80-85 ml was injected automatically with bolus tracking, and group B, n = 36; 18 men, 18 women; m

277 trigger delay for contrast media timing with bolus tracking.

278 n overall cerebral hemodynamics, epinephrine boluses transiently improved cerebral oxygenation (oxyge

279 ugs and the administration of corticosteroid boluses used in acute rejection.

280 ed before and after an oral fructose/glucose bolus using isotopic labeling with 1-(13) C(1) -acetate

281 89) or 0.9% saline alone (n = 386) in 250-mL boluses using an individualized hemodynamic algorithm du

282 increases in antibody production relative to bolus vaccination post prime.

283 ith an increased memory response compared to bolus vaccination.

284 utralizing antibody titers equivalent to two bolus vaccinations administered one month apart.

285 0 days plus an intraoperative corticosteroid bolus versus those receiving an intraoperative bolus onl

286 rmodilution after injection of a cold saline bolus via both centrally inserted central catheter and e

287 INTERPRETATION: High-dose bolus vitamin D supplementation of 100 000 IU colecalcif

288 d the median time to completion of the fluid bolus was 2.56 hours (interquartile range, 1.33 to 4.20)

289 ation to the administration of the andexanet bolus was 4.8+/-1.8 hours.

290 , intracoronary versus intravenous abciximab bolus was associated with a significantly reduced risk o

291 o 6 mL/kg predicted body weight, and a fluid bolus was given to identify fluid responders (increase i

292 iodine concentration, the mean iodixanol 270 bolus was larger compared with that of iopromide 300 (76

293 that hypoglycemia, as induced by an insulin bolus, was more pronounced and prolonged in ghrelin-KO m

294 mber of cardiac index-responders after fluid bolus were similar, the arterial load parameters did not

295 pplied to the skin, deliver ATRA as a single bolus, which is immediately taken up into the skin and c

296 ) reaction units as early as 5 minutes after bolus, which persisted during the entire duration of dru

297 Ten patients responded to somatostatin bolus, with a significant decrease in hepatic venous por

298 redictors of reaching a 30 mL/kg crystalloid bolus within 3 hours of sepsis onset (30by3); 2) assess

299 received intravenous thrombolysis (alteplase bolus) within 3 h of symptom onset in North America and

300 ulin delivery was calculated with a standard bolus wizard.